{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:51:39Z","timestamp":1777949499981,"version":"3.51.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic spontaneous urticaria often follows a prolonged and variable course, yet baseline disease duration is inconsistently reported in clinical trials, limiting interpretation of treatment outcomes. Accordingly, this systematic review aimed to evaluate baseline disease duration and reporting practices in phase-III trials for chronic spontaneous urticaria. Of 36 trials identified, only 16 (44.4%) reported baseline disease duration (mean: 5.30\u2009\u00b1\u20091.81 years). Differences in average disease duration were observed by publication date and intervention of interest. Definitions of disease duration were frequently unspecified, and no trials examined efficacy stratified by disease duration. This review ultimately highlights a gap in disease duration reporting, underscoring the need for standardization and transparency in clinical trial design.<\/jats:p>","DOI":"10.1186\/s13223-026-01026-0","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:32:45Z","timestamp":1774420365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline disease duration of chronic spontaneous urticaria participants in phase III clinical trials"],"prefix":"10.1186","volume":"22","author":[{"given":"Sana","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinesh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohannad","family":"Abu-Hilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"3","key":"1026_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jaci.2025.05.019","volume":"156","author":"R Lee","year":"2025","unstructured":"Lee R, Bernstein JA. Chronic spontaneous urticaria and chronic inducible urticaria. J Allergy Clin Immunol. 2025;156(3):546\u201356. https:\/\/doi.org\/10.1016\/j.jaci.2025.05.019.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1026_CR2","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s13555-023-00955-7","volume":"13","author":"AW Armstrong","year":"2023","unstructured":"Armstrong AW, Soong W, Bernstein JA. Chronic spontaneous urticaria: How to measure it and the need to define treatment success. Dermatol Ther (Heidelb). 2023;13(8):1629\u201346. https:\/\/doi.org\/10.1007\/s13555-023-00955-7.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"1026_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13555-021-00641-6","volume":"12","author":"MM Balp","year":"2022","unstructured":"Balp MM, Halliday AC, Severin T, et al. Clinical remission of chronic spontaneous urticaria (CSU): A targeted literature review. Dermatol Ther (Heidelb). 2022;12(1):15\u201327. https:\/\/doi.org\/10.1007\/s13555-021-00641-6.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"1026_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13223-020-00459-5","volume":"16","author":"P Stepaniuk","year":"2020","unstructured":"Stepaniuk P, Kan M, Kanani A. Natural history, prognostic factors and patient perceived response to treatment in chronic spontaneous urticaria. Allergy Asthma Clin Immunol. 2020;16(1):63. https:\/\/doi.org\/10.1186\/s13223-020-00459-5.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"1026_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.anai.2024.10.026","volume":"134","author":"DM Lang","year":"2024","unstructured":"Lang DM, Sheikh J, Joshi S, Bernstein JA. Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria. Annals Allergy Asthma Immunol. 2024;134(4):408\u2013e4173. https:\/\/doi.org\/10.1016\/j.anai.2024.10.026.","journal-title":"Annals Allergy Asthma Immunol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-026-01026-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:12:05Z","timestamp":1777857125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13223-026-01026-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1186\/s13223-026-01026-0","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}